Ad is loading...
LMCHX
Price
$38.08
Change
-$0.32 (-0.83%)
Updated
Nov 15 closing price
VMVAX
Price
$87.94
Change
-$0.20 (-0.23%)
Updated
Nov 15 closing price
Ad is loading...

LMCHX vs VMVAX

Header iconLMCHX vs VMVAX Comparison
Open Charts LMCHX vs VMVAXBanner chart's image
Lord Abbett Mid Cap Stock R6
Price$38.08
Change-$0.32 (-0.83%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Admiral
Price$87.94
Change-$0.20 (-0.23%)
VolumeN/A
CapitalizationN/A
LMCHX vs VMVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LMCHX vs. VMVAX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LMCHX is a Buy and VMVAX is a Buy.

FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.9B vs. LMCHX (1.23B). VMVAX pays higher dividends than LMCHX: VMVAX (2.14) vs LMCHX (0.70). LMCHX was incepted earlier than VMVAX: LMCHX (9 years) vs VMVAX (13 years). LMCHX is a more actively managed with annual turnover of: 41.00 vs. VMVAX (22.00). LMCHX has a lower initial minimum investment than VMVAX: LMCHX (0) vs VMVAX (3000). LMCHX annual gain was more profitable for investors over the last year : 29.31 vs. VMVAX (27.09). VMVAX return over 5 years is better than : 47.45 vs. LMCHX (38.68).
LMCHXVMVAXLMCHX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years13 years-
Gain YTD18.96417.355109%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.23B30.9B4%
Annual Yield % from dividends0.702.1433%
Returns for 1 year29.3127.09108%
Returns for 3 years5.5913.5441%
Returns for 5 years38.6847.4582%
Returns for 10 yearsN/A96.84-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LQR1.000.10
+10.94%
LQR House
GRBK69.45-0.50
-0.71%
Green Brick Partners
EXAS49.33-1.60
-3.14%
Exact Sciences Corp
EVER17.80-1.01
-5.37%
EverQuote
ADVM6.86-0.39
-5.38%
Adverum Biotechnologies